Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-01-22 @ 10:57 AM
Study NCT ID:
NCT03920566
Status:
UNKNOWN
Last Update Posted:
2019-04-22
First Post:
2019-03-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effect of ENZAlutamide on the Anti-Xa Levels of Patients Receiving DOACs
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CCR 5039
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None